SG153877A1 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
SG153877A1
SG153877A1 SG200904521-2A SG2009045212A SG153877A1 SG 153877 A1 SG153877 A1 SG 153877A1 SG 2009045212 A SG2009045212 A SG 2009045212A SG 153877 A1 SG153877 A1 SG 153877A1
Authority
SG
Singapore
Prior art keywords
cancer
treatment
hsp9o
leukaemia
preparations
Prior art date
Application number
SG200904521-2A
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Tracey Carter
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0414885A external-priority patent/GB0414885D0/en
Priority claimed from GB0420845A external-priority patent/GB0420845D0/en
Priority claimed from GB0503566A external-priority patent/GB0503566D0/en
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of SG153877A1 publication Critical patent/SG153877A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SG200904521-2A 2004-07-02 2005-06-30 Treatment of cancer SG153877A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
GB0420845A GB0420845D0 (en) 2004-09-20 2004-09-20 Treatment of cancer
US61442304P 2004-09-30 2004-09-30
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
US65445805P 2005-02-22 2005-02-22

Publications (1)

Publication Number Publication Date
SG153877A1 true SG153877A1 (en) 2009-07-29

Family

ID=39124615

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200904521-2A SG153877A1 (en) 2004-07-02 2005-06-30 Treatment of cancer

Country Status (8)

Country Link
JP (1) JP2008504355A (fr)
BR (1) BRPI0512889A (fr)
EC (1) ECSP077219A (fr)
IL (1) IL180460A (fr)
MA (1) MA28701B1 (fr)
MX (1) MX2007000263A (fr)
NZ (1) NZ552508A (fr)
SG (1) SG153877A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections

Also Published As

Publication number Publication date
MX2007000263A (es) 2007-07-20
BRPI0512889A (pt) 2008-04-15
ECSP077219A (es) 2007-03-29
JP2008504355A (ja) 2008-02-14
NZ552508A (en) 2009-10-30
IL180460A (en) 2010-12-30
IL180460A0 (en) 2007-06-03
MA28701B1 (fr) 2007-06-01

Similar Documents

Publication Publication Date Title
UA105210C2 (ru) Противораковая вакцина и ее применение
MX2007003907A (es) Agentes terapeuticos con toxicidad reducida.
CA115590S (en) Back therapy device
CA119221S (en) Blister package
IL184617A0 (en) Dr5 antibodies and uses thereof
TW200612918A (en) Lonidamine analogs
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
CA119341S (en) Goggle
MXPA05012421A (es) Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
TW200642684A (en) Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and taxanes
WO2008010991A3 (fr) Méthodes et compositions pour le traitement du cancer
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
UA99601C2 (ru) Применение антитела к cd151 для лечения первичных опухолей
LU92202I9 (fr)
HK1076055A1 (en) Covalent conjugates between artemisinin-related endoperoxides and iron- carrying proteins and methods of use
EP1503748A4 (fr) Medicaments servant a attenuer la neurotoxicite induite par le taxane
EA200970353A1 (ru) Комбинированное лекарственное средство
CA119778S (en) Package
PL1869185T3 (pl) Koniugat zawierający białko P21 do leczenia raka
PT1713438E (pt) Sabonete medicinal
CA105215S (en) Packaging with cosmetic composition
CA119697S (en) Loudspeaker housing
WO2007007152A3 (fr) Anticorps anti-madcam utilises pour le traitement de cancers metastatiques et du chlorome